Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| UW20-245 | Other Identifier | HKU/HA HKW IRB |
Not provided
Not provided
Not provided
COVID pandemic affected recruitment.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The proposed study aims to evaluate if improving sleep could enhance the intensive lifestyle intervention for improving weight loss and glycemic control in prediabetic individuals who have insomnia with short sleep duration. A cognitive behavioral intervention for insomnia with adjustments aimed at increasing sleep duration (CBT-Sleep) will be used for this study.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intensive Lifestyle Intervention (ILI) | Active Comparator | The ILI will consist of 8 group-based 90-min sessions focusing on modifying dietary and exercise habits with the goal of reducing 450kcal of daily calories and increasing physical activity to 150 minutes of exercise per week. |
|
| ILI enhanced with cognitive behavioral sleep intervention | Experimental | The ILI+Sleep intervention will consist of the same 8 sessions of ILI with additions of sleep components in each session. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Intensive Lifestyle Intervention | Behavioral | This intervention is an abbreviated version of the Diabetes Prevention Program, which has been shown to be effective in reducing the risk of developing type 2 diabetes. |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in HbA1C (%) | 12 weeks from baseline | |
| Changes in fasting glucose concentration (mg/dl) | 12 weeks from baseline | |
| Changes in 2-hr oral glucose tolerance (mg/dl) | 12 weeks from baseline |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in insomnia symptom severity | measured by the Insomnia Severity Index. The score ranges from 0 to 28. The higher the score, the greater the symptom severity | 12 weeks from baseline |
| Changes in subjective sleep onset latency |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Wai Sze Chan, PhD | The University of Hong Kong | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Queen Mary Hpspital | Hong Kong | Hong Kong | ||||
| The University of Hong Kong |
Deidentified data will be shared with other researchers for review purposes.
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D011236 | Prediabetic State |
| D007319 | Sleep Initiation and Maintenance Disorders |
| D012892 | Sleep Deprivation |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Intensive Lifestyle Intervention enhanced with Cognitive Behavioral Sleep Intervention | Behavioral | This intervention will consist of the same 8 sessions of ILI with additions of sleep components in each session. The additional sleep components will include (a) psychoeducation about the importance of sleep in weight control and glycemic control, (b) sleep hygiene, (c) stimulus control, (d) modifying maladaptive beliefs about sleep, (e) and, setting individualized sleep schedule and reviewing sleep schedule. |
|
measured by daily sleep diary
| 12 weeks from baseline |
| Changes in subjective wake after sleep onset | measured by daily sleep diary | 12 weeks from baseline |
| Changes in subjective total sleep time | measured by daily sleep diary | 12 weeks from baseline |
| Changes in objective sleep onset latency | measured by actigraphy | 12 weeks from baseline |
| Changes in objective wake after sleep onset | measured by actigraphy | 12 weeks from baseline |
| Changes in objective total sleep time | measured by actigraphy | 12 weeks from baseline |
| Changes in body weight (kg) | 12 weeks from baseline |
| Changes in psychological distress | the validated Chinese version of the Depression Anxiety Stress Scales (DASS-21)will be used. The score ranges from 0 to 63. The higher the score, the greater the distress | 12 weeks from baseline |
| Changes in quality of life | the validated Chinese version of the Satisfaction with Life Scale will be used to measure quality of life. The score ranges from 5 to 35. The higher the score, the greater the quality of life | 12 weeks from baseline |
| Changes in food craving | Measured by the Food Craving Questionnaire. The score ranges from 10 to 70. The higher the score, the greater the food craving | 12 weeks from baseline |
| Changes in acceptance of physical activity | Measured by the Physical Activity Acceptance and Action Questionnaire. The score ranges from 10 to 70. The higher the score, the greater acceptance. | 12 weeks from baseline |
| Changes in weight loss self efficacy | Measured by the Weight Loss Self Efficacy Scale. The score ranges from 0 to 100%. The higher the percentage, the greater the self-efficacy | 12 weeks from baseline |
| Changes in weight control strategies | Measured by the Weight Control Strategy Scale. The score ranges from 0 to 120. The higher the percentage, the more effective strategies are used | 12 weeks from baseline |
| Changes in dietary composition | Measured by the Chinese version of the 7-day Food Frequency Questionnaire | 12 weeks from baseline |
| Hong Kong |
| Hong Kong |
| D004700 | Endocrine System Diseases |
| D020919 | Sleep Disorders, Intrinsic |
| D020920 | Dyssomnias |
| D012893 | Sleep Wake Disorders |
| D009422 | Nervous System Diseases |
| D001523 | Mental Disorders |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |